文献速递心血管CT

冠状动脉周围脂肪组织衰减在将来发生急性冠脉综合征患者中的表现:ICONIC研究

Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC Study.
PubMed 文献 · Radiol Cardiothorac Imaging · 2025-01-01

该研究为ICONIC研究的回顾性子研究,纳入200对倾向性匹配的病例与对照(共400例患者、1174支可测量血管),分析冠状动脉CT血管成像测得的冠状动脉周围脂肪组织衰减(PCATa)。患者与对照组间PCATa无显著差异(-72.99 HU vs -73.96 HU,P=0.08),但在校正斑块体积、狭窄及高危斑块特征后的Cox模型中PCATa与急性冠脉综合征事件显著相关。

要点

  • PCATa在将来发生ACS患者与对照组间无显著差异(-72.99 HU vs -73.96 HU,P=0.08)。
  • 校正非钙化斑块后PCATa与ACS事件相关(HR 1.015,95%CI 1.001–1.028,P=0.03)。
  • PCATa可能不是识别未来ACS的单一标志物,但校正模型提示其独立于传统危险因素的小生物学效应。

核心结论

  • 风险因素与冠心病匹配的患者与对照间PCATa定量差异有限,提示PCATa可能不是识别未来ACS的单一有用标志物;但校正生存模型中的显著差异提示其独立于传统危险因素与未来ACS风险增加存在小的生物学效应。

研究设计与样本

  • ICONIC研究的回顾性子研究,为倾向性匹配的病例对照研究,从原始234对中识别出200对可分析病例与对照,共400例患者、1174支匹配的可测量血管。

关键影像表现/征象

  • PCATa采用近端冠状动脉血管周围脂肪的校正衰减值测量。
  • 患者与对照组间PCATa无显著差异(-72.99 HU ± 9.42 vs -73.96 HU ± 9.47;P=0.08)。

诊断标准与关键数值

  • 主要分析采用条件Cox模型及聚类稳健标准误预测患者水平的新发ACS。
  • 校正非钙化斑块时PCATa与ACS事件相关(HR 1.015;95%CI 1.001–1.028;P=0.03)。
  • 校正总斑块时PCATa与ACS事件相关(HR 1.015;95%CI 1.002–1.029;P=0.03)。
  • 校正狭窄与高危斑块特征时PCATa与ACS事件相关(HR 1.014;95%CI 1.000–1.028;P=0.049)。

临床应用与阅片要点

  • PCATa与未来ACS的关联在单变量比较中未达统计学显著,阅片时不宜将其作为单一预测指标。
  • 在报告CCTA时,PCATa的预后信息需结合非钙化斑块、总斑块、最大狭窄及高危斑块特征等综合评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose Pericoronary adipose tissue attenuation (PCATa) measured at coronary CT angiography (CCTA) is an imaging biomarker of coronary inflammation associated with long-term adverse cardiac events. The authors hypothesized that PCATa may independently identify patients at risk for acute coronary syndromes (ACS). Materials and Methods The authors performed a retrospective substudy of the Incident Coronary Syndromes Identified by Computed Tomography (ICONIC) study, a propensity-matched case-control study of patients with CCTA followed by ACS. Two hundred analyzable case and control pairs were identified from the original 234 pairs. PCATa was measured using the adjusted attenuation of fat around proximal coronary vessels. The primary analysis applied conditional Cox models with cluster-robust standard errors to predict patient-level incident ACS, with adjustment for quantitative plaque volumes and clinical reporting-oriented findings of maximal stenosis and high-risk plaque features (HRPF). Results A total of 400 patients with 1174 matched measurable vessels were included. PCATa was not significantly different between patients with future ACS versus controls (-72.99 HU ± 9.42 vs -73.96 HU ± 9.47; P = .08). Conversely, PCATa was significantly associated with incident ACS events in Cox models (adjusted for noncalcified plaque hazard ratio [HR]: 1.015; 95% CI: 1.001, 1.028; P = .03; adjusted for total plaque HR: 1.015; 95% CI: 1.002, 1.029; P = .03; adjusted for stenosis and HRPF HR: 1.014; 95% CI: 1.000, 1.028; P = .049). Conclusion Limited quantitative difference in PCATa between patients and controls matched for risk factors and coronary artery disease suggests that PCATa may not be a useful single marker to identify future ACS. Nonetheless, significant differences seen in adjusted survival models identify a small biologic effect for increased risk of future ACS independent of traditional risk factors. Keywords: CT-Angiography, Inflammation, Coronary Arteries, Acute Coronary Syndrome, Pericoronary Adipose Tissue Attenuation, Noncalcified Plaque, ICONIC Study, Cardiovascular Risk Clinical trials registration no. NCT02959099 Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Kwan AC, Tzolos E, Klein E, et al. Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC Study. Radiol Cardiothorac Imaging. 2025. PMID: 40539913. doi:10.1148/ryct.240200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。